GB2569056B - Methods for development and use of minimally polarized functional units in tissue applications using LGR4, LGR5 and LGR6 expressing epithelial stem cells - Google Patents

Methods for development and use of minimally polarized functional units in tissue applications using LGR4, LGR5 and LGR6 expressing epithelial stem cells Download PDF

Info

Publication number
GB2569056B
GB2569056B GB201902819A GB201902819A GB2569056B GB 2569056 B GB2569056 B GB 2569056B GB 201902819 A GB201902819 A GB 201902819A GB 201902819 A GB201902819 A GB 201902819A GB 2569056 B GB2569056 B GB 2569056B
Authority
GB
United Kingdom
Prior art keywords
lgr4
lgr5
development
methods
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB201902819A
Other languages
English (en)
Other versions
GB2569056A (en
GB201902819D0 (en
Inventor
M Lough Denver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RegenETP Inc
Original Assignee
PolarityTE Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56078499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB2569056(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by PolarityTE Inc filed Critical PolarityTE Inc
Publication of GB201902819D0 publication Critical patent/GB201902819D0/en
Publication of GB2569056A publication Critical patent/GB2569056A/en
Application granted granted Critical
Publication of GB2569056B publication Critical patent/GB2569056B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/362—Skin, e.g. dermal papillae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Developmental Biology & Embryology (AREA)
GB201902819A 2014-12-02 2015-12-01 Methods for development and use of minimally polarized functional units in tissue applications using LGR4, LGR5 and LGR6 expressing epithelial stem cells Active GB2569056B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462086526P 2014-12-02 2014-12-02
US14/954,335 US10926001B2 (en) 2014-12-02 2015-11-30 Methods related to minimally polarized functional units
GB1710646.9A GB2549872A (en) 2014-12-02 2015-12-01 Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using LGR4, LGR5 and LGR6

Publications (3)

Publication Number Publication Date
GB201902819D0 GB201902819D0 (en) 2019-04-17
GB2569056A GB2569056A (en) 2019-06-05
GB2569056B true GB2569056B (en) 2020-01-01

Family

ID=56078499

Family Applications (2)

Application Number Title Priority Date Filing Date
GB201902819A Active GB2569056B (en) 2014-12-02 2015-12-01 Methods for development and use of minimally polarized functional units in tissue applications using LGR4, LGR5 and LGR6 expressing epithelial stem cells
GB1710646.9A Withdrawn GB2549872A (en) 2014-12-02 2015-12-01 Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using LGR4, LGR5 and LGR6

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1710646.9A Withdrawn GB2549872A (en) 2014-12-02 2015-12-01 Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using LGR4, LGR5 and LGR6

Country Status (21)

Country Link
US (7) US10926001B2 (https=)
EP (2) EP4438128A3 (https=)
JP (3) JP6791854B2 (https=)
KR (5) KR20190111167A (https=)
CN (1) CN107250348B (https=)
AU (3) AU2015355187C1 (https=)
BR (1) BR112017011808A2 (https=)
CA (1) CA2969707C (https=)
CO (1) CO2017006640A2 (https=)
CR (1) CR20170296A (https=)
EA (1) EA201791125A1 (https=)
GB (2) GB2569056B (https=)
HK (1) HK1250515A1 (https=)
IL (2) IL252613B (https=)
MX (2) MX2017007243A (https=)
MY (1) MY184931A (https=)
NZ (2) NZ733433A (https=)
PH (1) PH12017501009B1 (https=)
SG (2) SG11201704502RA (https=)
WO (1) WO2016089825A1 (https=)
ZA (1) ZA201703907B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201908271WA (en) * 2017-03-14 2019-10-30 Juno Therapeutics Inc Methods for cryogenic storage
AU2019212976A1 (en) * 2018-01-26 2020-07-23 Polarityte, Inc. Complex living interface-coordinated self-assembling materials (CLICSAM)
EP3743125A4 (en) * 2018-01-26 2022-03-02 Polarityte, Inc. BIOMATERIAL ACCELERATING SUBSTRATE WITH COMPOSITE INTERFACE
FR3082123B1 (fr) 2018-06-07 2020-10-16 Urgo Rech Innovation Et Developpement Pansement cellularise et son procede de fabrication
JP2024006681A (ja) * 2022-07-04 2024-01-17 学校法人近畿大学 生体材料
WO2025166131A1 (en) * 2024-02-01 2025-08-07 Board Of Regents, The University Of Texas System Compositions and methods for treating bone and muscle injuries

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120196312A1 (en) * 2009-02-03 2012-08-02 Toshiro Sato Culture medium for epithelial stem cells and organoids comprising the stem cells

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040126881A1 (en) 2002-09-06 2004-07-01 Vincent Ronfard Fibrin cell supports and methods of use thereof
WO2006008009A2 (en) 2004-07-23 2006-01-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with leucine-rich repeat-containing gpcr 6 (lgr6)
US20060134074A1 (en) 2004-08-30 2006-06-22 Naughton Gail K Compositions and methods for promoting hair growth
EP1942957B1 (en) * 2005-10-27 2012-07-11 Coloplast A/S Biodegradable scaffold with ecm material
WO2008008009A1 (en) 2006-07-13 2008-01-17 St. Jude Medical Ab Medical information management in a patient information hub system
US8366723B2 (en) 2006-08-03 2013-02-05 Rassman Licensing, Llc Hair harvesting device and method with localized subsurface dermal fluid insertion
US7998737B2 (en) 2006-09-12 2011-08-16 Deutsches Krebsforschungszentrum Cell culture of keratinocytes under non-differentiating conditions
GB201111244D0 (en) 2011-06-30 2011-08-17 Konink Nl Akademie Van Wetenschappen Knaw Culture media for stem cells
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
FI20095355A0 (fi) 2009-04-01 2009-04-01 Helsingin Yliopisto Regeneroituva aktiivinen matriisi ja sen käytöt
CN102498221A (zh) 2009-06-25 2012-06-13 株式会社资生堂 基于aff-4表达筛选抗白发剂的方法
US20110130711A1 (en) 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
JP6023049B2 (ja) 2010-06-30 2016-11-09 チェン，ジンシー 皮膚組織細胞の集合体の製造方法及びその用途
GB201106395D0 (en) 2011-04-14 2011-06-01 Hubrecht Inst Compounds
EP2771454B1 (en) 2011-10-27 2019-07-24 Universität Leipzig Method for deriving melanocytes from the hair follicle outer root sheath and preparation for grafting
JP6186997B2 (ja) 2012-08-07 2017-08-30 日油株式会社 塗布型帯電防止剤
US9655930B2 (en) 2012-10-01 2017-05-23 Aderans Research Institute, Inc. Compositions and methods for producing reconstituted skin
US20140106447A1 (en) 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells
LT2970890T (lt) 2013-03-14 2020-07-10 The Brigham And Women`S Hospital, Inc. Kompozicijos ir būdai, skirti epitelinių kamieninių ląstelių padauginimui ir kultivavimui
US9592257B2 (en) 2013-10-11 2017-03-14 MWV Cell, LLC Complete human skin organ generated from culture-expanded cells
CN103550828B (zh) * 2013-10-17 2016-01-27 中国科学院动物研究所 一种基于毛囊干细胞和硅凝胶敷料的皮肤重建方法
TWI548413B (zh) 2014-11-07 2016-09-11 國立臺灣大學 誘導毛囊新生的皮膚萃取物、組合物及其用途

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120196312A1 (en) * 2009-02-03 2012-08-02 Toshiro Sato Culture medium for epithelial stem cells and organoids comprising the stem cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal of Investigative Dermatology, 2010, Vol 130 No 8, BIEDERMANN ET AL., Human Eccrine Sweat Gland Cells Can Reconstitute a Stratified Epidermis, pages 1996-2009 *

Also Published As

Publication number Publication date
US12465669B2 (en) 2025-11-11
CA2969707A1 (en) 2016-06-09
US20190046691A1 (en) 2019-02-14
JP2019088299A (ja) 2019-06-13
CA2969707C (en) 2019-08-20
EP3227431C0 (en) 2025-01-29
HK1245327A1 (zh) 2018-08-24
IL287488B2 (en) 2023-06-01
PH12017501009B1 (en) 2022-01-21
AU2019240603A1 (en) 2019-10-17
EP3227431A1 (en) 2017-10-11
ZA201703907B (en) 2023-03-29
BR112017011808A2 (pt) 2018-02-27
JP6791854B2 (ja) 2020-11-25
MX2017007243A (es) 2018-01-25
CN107250348A (zh) 2017-10-13
CN107250348B (zh) 2021-09-03
SG11201704502RA (en) 2017-06-29
US20180154044A1 (en) 2018-06-07
EP4438128A2 (en) 2024-10-02
US11596714B2 (en) 2023-03-07
NZ733433A (en) 2019-08-30
KR20210043024A (ko) 2021-04-20
AU2023202857A1 (en) 2023-05-25
IL252613B (en) 2021-12-01
GB2549872A (en) 2017-11-01
CO2017006640A2 (es) 2017-11-21
US11338060B2 (en) 2022-05-24
HK1250515A1 (zh) 2018-12-21
US20160151540A1 (en) 2016-06-02
GB2569056A (en) 2019-06-05
EP3227431B1 (en) 2025-01-29
AU2015355187B2 (en) 2019-10-03
JP2017538411A (ja) 2017-12-28
SG10201914058QA (en) 2020-03-30
KR20180136587A (ko) 2018-12-24
KR20170098844A (ko) 2017-08-30
US10926001B2 (en) 2021-02-23
CR20170296A (es) 2018-01-25
EA201791125A1 (ru) 2018-06-29
US11266765B2 (en) 2022-03-08
AU2019240603B2 (en) 2023-02-09
US20210322643A1 (en) 2021-10-21
US20230181797A1 (en) 2023-06-15
GB201710646D0 (en) 2017-08-16
EP3227431A4 (en) 2019-01-02
JP2020182880A (ja) 2020-11-12
US20220241464A1 (en) 2022-08-04
EP4438128A3 (en) 2024-11-13
IL252613A0 (en) 2017-07-31
MX2023001655A (es) 2023-04-24
US20180154043A1 (en) 2018-06-07
US11000629B2 (en) 2021-05-11
KR20180136588A (ko) 2018-12-24
KR20190111167A (ko) 2019-10-01
AU2015355187C1 (en) 2020-02-20
AU2015355187A1 (en) 2017-06-29
IL287488A (en) 2021-12-01
NZ755260A (en) 2021-12-24
PH12017501009A1 (en) 2017-12-11
WO2016089825A1 (en) 2016-06-09
MY184931A (en) 2021-04-30
GB201902819D0 (en) 2019-04-17

Similar Documents

Publication Publication Date Title
IL287488A (en) Methods for the development and use of minimally polarized microaggregate cell units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells
SI3215601T1 (sl) Postopki za transdukcijo in obdelavo celic
GB2525716B (en) Electrochemical system with real time modification of composition and use of complex wave form in same
HUE045872T2 (hu) Sejteket penetráló peptidek és ezek elõállítására és alkalmazására szolgáló eljárások
IL240475A0 (en) Tubulin compounds, methods for their preparation and use
GB201600635D0 (en) Anchor for inplantation in body tissue
SI3218005T1 (sl) Z glikanom delujoče spojine, in postopki uporabe
EP3200809A4 (en) Amniotic membrane powder and its use in wound healing and tissue engineering constructs
EP3204593A4 (en) Device and system for use in monitoring coring operations
EP3151326A4 (en) Nonaqueous electrolyte and electricity-storing device in which same is used
HRP20182134T1 (hr) Triazinski spoj i njegova upotreba u medicinske svrhe
SG11201704423SA (en) Aminoacid-based composition for fibroelastin recovery in dermal connective tissues
EP3107996A4 (en) Tscm cells and methods for use
DK3569697T3 (da) Stamcelleterapi i endometriumpatologier
EP3203835A4 (en) Method and composition for hypothermic storage of placental tissue
EP3233808A4 (en) Methods for measurement of inhibition of c-jun n-terminal kinase in skin
PL3126546T3 (pl) Ogniwo elektrochemiczne do elektrolizy wody w postaci cieczy lub pary, sposób wytwarzania i zastosowania
DK3145548T3 (en) Aqueous gel composition and its use
EP3191413A4 (en) Uses of melanin in water
PT2968420T (pt) Utilização de células estaminais placentárias no tratamento de lesão renal aguda
HK40009324A (en) Methods for development and use of minimally polarized functional units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells
HK40009324B (en) Methods for development and use of minimally polarized functional units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells
EP3167272A4 (en) Aqueous tissue clearing solution and uses thereof
HK1197719B (en) Improvements in and relating to ophthalmoscopes
AU2014904345A0 (en) Stem cell line and use thereof

Legal Events

Date Code Title Description
R108 Alteration of time limits (patents rules 1995)

Free format text: EXTENSION ALLOWED

Effective date: 20191113

Free format text: EXTENSION APPLICATION

Effective date: 20191107

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40009324

Country of ref document: HK